BioStock: Large shareholders about their increased holding in Chordate Medical

Last week, Chordate Medical announced that two major shareholders, Isac Brandberg AB and related parties and Jinderman & Partners AB, have increased their shareholding in the company. This is a clear sign of the two shareholders’ confidence in Chordate Medical and the company’s treatment for chronic nasal congestion and chronic migraine. BioStock contacted two representatives from Jinderman & Partners and Isac Brandberg to hear more about their expectations on Chordate Medical and why they have chosen to increase their holdings in the company.

Read the full article at biostock.se:

https://www.biostock.se/en/large-shareholders-about-their-increased-holding-in-chordate-medical/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se